HUMAN PROTEINS, POLYNUCLEOTIDES ENCODING THEM AND METHODS OF USING THE SAME

Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypep...

Full description

Saved in:
Bibliographic Details
Main Authors MALYANKAR, URIEL, STONE, DAVID, SPYTEK, KIMBERLY, A, FURTAK, KATARZYNA, SMITHSON, GLENNDA, VERNET, CORINE, A., M, GERLACH, VALERIE, ANDERSON, DAVID, CASMAN, STACIE, EDINGER, SHLOMIT, MILLET, ISABELLE, GILBERT, JENNIFER, LI, LI, MISHRA, VISHNU, GANGOLLI, ESHA, A, SHENOY, SURESH, PADIGARU, MURALIDHARA, TAUPIER, RAYMOND, J., JR, GUNTHER, ERIK, BLALOCK, ANGELA
Format Patent
LanguageEnglish
French
Published 12.02.2004
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins. La présente invention concerne des séquences d'acides nucléiques codant des polypeptides selon l'invention. L'invention concerne également des polypeptides codés par ces séquences d'acides nucléiques, ainsi que des anticorps se liant immunospécifiquement au polypeptide, mais aussi des dérivés, des variants, des mutants ou des fragments du polypeptide, du polynucléotide ou de l'anticorps. L'invention concerne enfin des procédés thérapeutiques, de diagnostic, et de recherche convenant au diagnostic, au traitement et à la prévention de troubles impliquant l'un ou l'autre de ces protéines et acides nucléiques humains.
Bibliography:Application Number: WO2001US50925